Healthcare - Medical - Healthcare Information Services - NYSE - US
$ 12.38
-2.29 %
$ 1.44 B
Market Cap
-13.46
P/E
CASH FLOW STATEMENT
143 M
OPERATING CASH FLOW
-416 M
INVESTING CASH FLOW
281 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Evolent Health, Inc.
| Net Income | -113 M |
| Depreciation & Amortization | 123 M |
| Capital Expenditures | -28.7 M |
| Stock-Based Compensation | 40.5 M |
| Change in Working Capital | 21.9 M |
| Others | 305 M |
| Free Cash Flow | 114 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||
| Net Income | (113.0) | (19.2) | (37.6) | (334.2) | (305.6) | (54.2) | (69.8) | (226.8) | 319.8 | (25.2) | 20.0 | (19.3) |
| Depreciation & Amortization | 123.4 | 67.2 | 60.0 | 61.5 | 60.9 | 44.5 | 32.4 | 17.2 | 7.2 | 0 | 1.2 | 0.1 |
| Deferred Income Tax | (31.3) | 0.3 | (0.5) | (1.1) | (23.1) | 44 K | (7.3) | (10.8) | 23.5 | 0 | 4.2 | 0 |
| Stock Based Compensation | 40.5 | 34.0 | 16.7 | 14.6 | 15.6 | 17.6 | 20.4 | 22.5 | 14.7 | 0 | 91 K | 87 K |
| Other Operating Activities | 101.1 | 10.5 | 13.8 | 298.4 | 209.2 | 6.2 | 3.6 | 166.7 | (387.2) | 75.1 | (45.4) | 6.4 |
| Change in Working Capital | 21.9 | (104.4) | (13.6) | (55.3) | 0.3 | (34.9) | (7.3) | (4.4) | 2.2 | (49.9) | 6.2 | (1.8) |
| Cash From Operations | 142.6 | (11.6) | 38.7 | (16.2) | (42.6) | (20.7) | (28.0) | (35.5) | (19.8) | (75.1) | (13.6) | (12.8) |
| INVESTING CASH FLOW | ||||||||||||
| Capital Expenditures | (28.7) | (38.4) | (25.0) | (29.5) | (35.5) | (39.5) | (27.8) | (15.5) | (6.5) | (11.0) | (10.4) | (2.3) |
| Other Items | (386.8) | (220.8) | 9.2 | 290.5 | (146.1) | (120.8) | 15.6 | (82.3) | (37.2) | 7.5 | (15.5) | (1.4) |
| Cash From Investing Activities | (415.5) | (259.1) | (15.8) | 261.1 | (181.6) | (160.4) | (12.3) | (97.8) | (43.7) | (3.6) | (25.9) | (3.8) |
| FINANCING CASH FLOW | ||||||||||||
| Common Stock Repurchased | 0 | (18.3) | (3.9) | (1.9) | (2.6) | (1.2) | 0 | (0.4) | 0 | 0 | 100 K | 0 |
| Total Debt Repaid | 183.3 | 160.3 | (37.7) | 13.5 | 62.6 | 167.2 | 0 | 121.2 | 0 | 0 | 23.0 | 0 |
| Dividends Paid | (18.8) | (14.9) | (1.3) | (20.0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 104.3 | (18.3) | 9.4 | (3.5) | (95.6) | 106.8 | (1.4) | (0.4) | (1.2) | (1.4) | 11.3 | 0 |
| Cash From Financing Activities | 281.3 | 131.5 | (29.5) | (11.9) | (35.5) | 274.0 | 165.6 | 122.1 | 209.2 | (1.4) | 34.3 | 4.5 |
| CHANGE IN CASH | ||||||||||||
| Net Change In Cash | 8.3 | (139.8) | (6.6) | 233.1 | (259.8) | 93.0 | 125.3 | (11.2) | 145.7 | (80.0) | (5.3) | (12.0) |
| FREE CASH FLOW | ||||||||||||
| Free Cash Flow | 113.8 | (49.9) | 13.8 | (45.7) | (78.2) | (60.2) | (55.8) | (51.0) | (26.3) | (86.1) | (24.1) | (15.1) |